eWeek2d
‘Solving All Disease’ Using AI is the Mission of Alphabet’s Isomorphic Labs – Its $600M in Funding Will Help
Isomorphic Labs, an Alphabet-backed AI biotech firm, raised $600M to boost its AI drug design engine, expand clinical ...
Alphabet’s Isomorphic Labs raises $600M in first funding round for AI drug business
The London-based business – which launched in 2021 – will use the funds to further its research, expand its team and continue ...
Google DeepMind outlines safety framework for future AGI development
Though the paper does discuss AGI through what Google DeepMind is doing, it notes that no single organization should tackle ...
Alphabet's AI Power Play Is Hiding In Plain Sight - And Investors Are Missing It
Alphabet's AI integration, robust cash flow, and profitable Google Cloud make it a top investment choice. See more on GOOG ...
Alphabet’s Isomorphic Labs raises $600 million to advance AI drug design
Isomorphic Labs raised $600 million in its first external funding round, led by Thrive Capital with participation from GV and ...
Google’s DeepMind Tightens AI Research Release amid AI Competition
AI unit, has placed strict controls over the release of its research papers to maintain its competitive edge in ...
Alphabet spinout Isomorphic Labs raises $600M for its AI drug design engine
AlphaFold 3, the improved version of the model used by Isomorphic Labs’ drug design engine, debuted last May. It can predict ...
Alphabet’s AI drug discovery platform Isomorphic Labs raises $600M from Thrive
Isomorphic Labs, the AI drug-discovery platform that was spun out of Google's DeepMind in 2021, has raised external capital for the first time. The $600 ...
Alphabet: Leading The AI Race
Alphabet’s Gemini 2.5 Pro sets new AI benchmarks, powered by DeepMind and custom TPUs. Learn why GOOG stock offers long-term ...
Google Gemini executive Sissie Hsiao to step down
Alphabet's Google is replacing Sissie Hsiao, who led the development of the artificial intelligence chatbot Bard, now known ...